Hemostemix (CVE:HEM) Share Price Crosses Below Fifty Day Moving Average of $0.21

Hemostemix Inc. (CVE:HEMGet Rating) shares passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of C$0.21 and traded as low as C$0.16. Hemostemix shares last traded at C$0.18, with a volume of 98,500 shares traded.

Hemostemix Stock Performance

The stock has a market cap of C$13.25 million, a price-to-earnings ratio of -1.75 and a beta of 0.61. The business has a fifty day simple moving average of C$0.21 and a 200 day simple moving average of C$0.18.

About Hemostemix

(Get Rating)

Hemostemix Inc, a biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of critical limb ischemia in Canada and the United States, as well as for the treatment of heart and peripheral arterial diseases.

See Also

Receive News & Ratings for Hemostemix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hemostemix and related companies with MarketBeat.com's FREE daily email newsletter.